Trials / Completed
CompletedNCT02592200
Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women
A Double Blind Placebo-Controlled Study on the Effect of the Probiotic Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women - Proof of Concept
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- BioGaia AB · Industry
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The primary objective is to determine the change in frequency of complete spontaneous bowel movements (CSBMs) after 4 weeks of oral supplementation with Lactobacillus gasseri DSM 27123 in healthy adult women with functional constipation.
Detailed description
Subjects to complete study diaries, number of SBM, CSBM, form of faeces (according to the Bristol Stool Form scale), pain during defecation (according to the visual analogue scale \[VAS\] 0-100), time spent at each evacuation, episodes of faecal incontinence, number of ingested capsules of investigational product will be recorded daily by the subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactobacillus gasseri DSM 27123 | 109 CFU (divided in two doses) per day for 28 days |
| DIETARY_SUPPLEMENT | Placebo | Two doses per day for 28 days |
Timeline
- Start date
- 2015-10-05
- Primary completion
- 2016-06-21
- Completion
- 2016-07-31
- First posted
- 2015-10-30
- Last updated
- 2021-01-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02592200. Inclusion in this directory is not an endorsement.